Patent · US Active

Methods for treating inflammatory conditions

US8716294B2 · kind B2 · utility

0Cited by
1References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 9, 2007
Grant dateMay 6, 2014
Priority date
Expiry dateApr 24, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2800/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising tenilsetam or pharmaceutically acceptable salts thereof that are useful in modulating inflammation. In particular, the compounds or pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder involving inflammation, including, but not limited to, delayed type hypersensitivity and contact hypersensitivity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.